Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009275
Filing Date
2025-05-08
Accepted
2025-05-08 16:28:33
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 680700
2 EX-31.1 ex31-1.htm EX-31.1 19326
3 EX-31.2 ex31-2.htm EX-31.2 15323
4 EX-32.1 ex32-1.htm EX-32.1 7534
5 EX-32.2 ex32-2.htm EX-32.2 5410
  Complete submission text file 0001641172-25-009275.txt   4620176

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE idxg-20250331.xsd EX-101.SCH 36116
7 XBRL CALCULATION FILE idxg-20250331_cal.xml EX-101.CAL 60829
8 XBRL DEFINITION FILE idxg-20250331_def.xml EX-101.DEF 109681
9 XBRL LABEL FILE idxg-20250331_lab.xml EX-101.LAB 283267
10 XBRL PRESENTATION FILE idxg-20250331_pre.xml EX-101.PRE 229902
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 707309
Mailing Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054
Business Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

EIN.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24249 | Film No.: 25926723
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)